Best Phosphodiesterase 4 Inhibitor for pulmonary disease, chronic obstructive

The 2 Phosphodiesterase 4 Inhibitor options we list for pulmonary disease, chronic obstructive are all Roflumilast— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for pulmonary disease, chronic obstructive or the full Phosphodiesterase 4 Inhibitor class. Not medical advice — always consult a professional.

Quick answer: Of the 2 phosphodiesterase 4 inhibitor drugs we rate for pulmonary disease, chronic obstructive, all are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for pulmonary disease, chronic obstructive; the right choice depends on your situation, so confirm it with your prescriber.

These are all Roflumilastin different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.

All 2 phosphodiesterase 4 inhibitor products